Cover Image
市場調查報告書

醫療用冷鏈物流的全球市場分析·預測 (2016∼2020年)

Global Healthcare Cold Chain Logistics Market Report & Forecast (2016-2020)

出版商 IMARC Services Pvt. Ltd. 商品編碼 328219
出版日期 內容資訊 英文 112 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
醫療用冷鏈物流的全球市場分析·預測 (2016∼2020年) Global Healthcare Cold Chain Logistics Market Report & Forecast (2016-2020)
出版日期: 2015年04月06日 內容資訊: 英文 112 Pages
簡介

醫療用冷鏈物流服務的全球市場現在受到溫度敏感性高的醫藥品銷售額增加的影響,而正在急速成長中。全球醫療用冷鏈物流的市場規模,預測將從目前的85億美元,到2020年擴大到約134億美元的規模。

在本報告提供全球醫療·製藥產業的冷鏈物流服務的相關分析,提供醫療用低溫運輸結構·特性和流通流程,物流上的必要條件 (溫度敏感度高的醫藥品處理方法等),彙整整體市場趨勢預測,各部門的詳細趨勢,主要企業簡介等資訊,為您概述為以下內容。

第1章 調查手法·市場定義

第2章 摘要整理

第3章 全球醫療冷鏈物流服務市場:目前趨勢

  • 醫療用低溫運輸產品的急劇成長
  • 由於溫度敏感度高的醫藥品登場,物流上的需求明顯化
  • 由於研究·製造工程的外包化趨勢,物流上的需求擴大
  • 對於醫藥品的保存性問題,法規方面日益受重視
  • 在供應商的決策中,成本經常不是最重要的

第4章 醫療用冷鏈物流:如何運用?

  • 低溫運輸的包裝·運輸方式
    • 乾冰
    • 液態氮
    • 凝膠包裝
  • 低溫運輸的設定
    • 初期的考察
    • 選擇恰當的模式
    • 法規/報關手續
    • 最後階段
    • 品質保證
  • 低溫運輸的包裝·運輸成本建模

第5章 醫療用冷鏈物流服務市場

  • 目前市場趨勢
  • 各產品的市場區隔
  • 各市場區隔的市場區隔
    • 運輸
      • 現在·過去的市場趨勢
      • 各運輸方法的市場區隔
      • 市場預測
    • 包裝
    • 檢測設備
  • 各地區的市場區隔
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區 (ROW)

第6章 全球醫療用低溫運輸產品市場

  • 過去·現在·未來市場趨勢
  • 市場區隔
    • 生物醫藥品
      • 過去·現在·未來市場趨勢
      • 生物醫藥品低溫物流輸送系統的必要條件
      • 生物醫藥品低溫物流輸送系統的市場機會
    • 疫苗
    • 臨床實驗材料

第7章 醫療低溫運輸物流市場上課題

第8章 溫度敏感度高的醫藥品之國際貿易

  • 溫度敏感度高的醫藥品出口額
    • 現在·過去的市場趨勢
    • 主要出口國
  • 溫度敏感度高的醫藥品進口額
    • 現在·過去的市場趨勢
    • 主要進口國

第9章 主要企業簡介

  • World Courier
  • DHL
  • Fedex
  • United Parcel Service
  • Kuehne and Nagel
  • Cavalier Logistics
  • DB Schenker
  • Life ConEx
  • American Airlines Cargo
  • Continental Air Cargo
  • Marken

圖表一覽

目錄
Product Code: SRHL0415A

Driven by a strong growth in the sales of temperature sensitive healthcare products, the demand for cold chain logistic services is currently experiencing explosive growth. IMARC Group, one of the world's leading research and advisory firms, finds that the total size of the healthcare cold chain logistic services market is expected to expand from its current figures of US$ 8.5 billion to nearly US$ 13.4 billion by 2020.

IMARC's new report entitled “Global Healthcare Cold Chain Logistics Market Report & Forecast (2016-2020)”, which is the fourth edition of our highly acclaimed publication, provides a comprehensive insight into the logistic opportunities in the global healthcare market. The study, that has been undertaken using both desk based and qualitative primary market research, has analyzed three key aspects of the global healthcare cold chain logistics market.The first aspect involves an in-depth understanding on the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products. The second aspect involves the quantification of the global healthcare cold chain logistic services market and a comprehensive evaluation of its various segments. The third aspect involves the quantification of the global market for temperature sensitive healthcare products into three major classes and evaluation of the current and future opportunities in each of these classes.

What we have achieved in this report?

Understanding the Healthcare Cold Chain Distribution Process

Focus of the Analysis:

  • Understanding the various methods of cold chain distribution and their advantages/disadvantages
  • Understanding the cold chain requirements for various temperature sensitive healthcare products and the impact of temperature excursions
  • Understanding the key steps required in the setting and organization of an efficient cold chain distribution process
  • Understanding the various costs involved in cold chain transportation and comparing it with non-cold chain transportation

Comprehensive Market Analysis of the Healthcare Cold Chain Logistic Services Market

Focus of the analysis:

  • Analyzing and evaluating the global healthcare cold chain logistic services market
  • Analyzing and evaluating the global healthcare cold chain logistic services market by product
    • Biopharmaceuticals
    • Vaccines
    • Clinical trials
  • Analyzing and evaluating the global healthcare cold chain logistic services by segment
    • Transportation
    • Packaging
    • Instrumentation
  • Analyzing and evaluating the global healthcare cold chain logistic services market by Region
    • North America
    • Europe
    • Asia Pacific

Comprehensive Market Analysis of Temperature Sensitive Healthcare Products:

Classes Covered: Biopharmaceuticals, Vaccines and Clinical Trial Materials

Focus of the Analysis in Each Class:

  • Drivers and challenges
  • Historical and future sales trends
  • Logistic requirements
  • Impact of temperature excursions
  • Opportunities in cold chain services

Table of Contents

1. Research Methodology & Market Definitions

2. Executive Summary

3. Current Trends in the Global Healthcare Cold Chain Logistic Services Market

  • 3.1. Healthcare Cold Chain Products are Exhibiting Exponential Growth
  • 3.2. Temperature Sensitive Healthcare Products Have Well Defined Logistic Needs
  • 3.3. Outsourcing Trends in Research and Manufacturing Have Increased Logistic Demands
  • 3.4. Increasing Regulatory Focus on the Integrity of Transported Healthcare Products
  • 3.5. Cost is Not Always the Most Important Driver in Supplier Decisions

4. Healthcare Cold Chain Logistics: How Does It Operate?

  • 4.1. Cold Chain Packaging and Transportation Methods
    • 4.1.1. Dry Ice
    • 4.1.2. Liquid Nitrogen
    • 4.1.3. Gel Packs
  • 4.2. Setting Up a Cold Chain
    • 4.2.1. Initial Considerations
    • 4.2.2. Choosing the Correct Model
    • 4.2.3. Regulatory/Custom Clearance
    • 4.2.4. Final Stages
    • 4.2.5. Quality Assurance
  • 4.1. Modeling the Cost of Cold Chain Packaging and Transportation

5. The Healthcare Cold Chain Logistic Services Market

  • 5.1. Current Market Trends
  • 5.2. Market Breakup by Product
    • 5.2.1. Clinical Trial Materials
    • 5.2.2. Vaccines
    • 5.2.3. Biopharmaceuticals
  • 5.3. Market Breakup by Segment
    • 5.3.1. Transportation
      • 5.3.1.1. Current and Historical Market Trends
      • 5.3.1.2. Market Breakup by Transportation Type
      • 5.3.1.3. Market Forecast
    • 5.3.2. Packaging
      • 5.3.2.1. Current and Historical Market Trends
      • 5.3.2.2. Market Breakup by Packaging Type
      • 5.3.2.3. Market Forecast
    • 5.3.3. Instrumentation
      • 5.3.3.1. Current and Historical Market Trends
      • 5.3.3.1. Market Breakup by Instrumentation Type
      • 5.3.3.1. Market Forecast
      • 5.4. Market Breakup by Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Rest of the World

6. The Global Healthcare Cold Chain Products Market

  • 6.1. Historical, Current and Future Market Trends
  • 6.2. Market Segments
    • 6.2.1. Biopharmaceuticals
      • 6.2.1.1. Historical, Current and Future Market Trends
      • 6.2.1.2. Cold Chain Requirements for Biopharmaceuticals
      • 6.2.1.3. Cold Chain Opportunities for Biopharmaceuticals
    • 6.2.2. Vaccines
      • 6.2.2.1. Historical, Current and Future Market Trends
      • 6.2.2.2. Cold Chain Requirements for Vaccines
      • 6.2.2.3. Cold Chain Opportunities for Vaccines
    • 6.2.3. Clinical Trial Materials
      • 6.2.3.1. Historical, Current and Future Market Trends
      • 6.2.3.2. Cold Chain Requirements for Clinical Trial Materials
      • 6.2.3.3. Cold Chain Opportunities for Clinical Trial Materials

7. Challenges in the Healthcare Cold Chain Logistics Market

8. Global Trade of Temperature Sensitive Healthcare Products

  • 8.1. Global Exports of Temperature Sensitive Healthcare Products
    • 8.1.1. Current and Historical Trends
    • 8.1.2. Major Exporting Countries
  • 8.2. Global Imports of Temperature Sensitive Healthcare Products
    • 8.2.1. Current and Historical Trends
    • 8.2.2. Major Importing Countries

9. Key Company Profiles

  • 9.1. World Courier
  • 9.2. DHL
  • 9.3. Fedex
  • 9.4. United Parcel Service
  • 9.5. Kuehne and Nagel
  • 9.6. Cavalier Logistics
  • 9.7. DB Schenker
  • 9.8. Life ConEx
  • 9.9. American Airlines Cargo
  • 9.10. Continental Air Cargo
  • 9.11. Marken

List of Figures

  • Figure 3.1: Global-Healthcare Cold & Non Cold Chain Products Market (in Billion US$), 2007-2014
  • Figure 3.2: Global-Healthcare Cold & Non Cold Chain Products Market Forecast (in Billion US$), 2015-2020
  • Figure 3.3: Global-Potency of the Tetanus Component of a DTP Vaccine Stored for 45 Days at Various Temperatures
  • Figure 3.4: Global-Contract Research & Manufacturing Market (in Billion US$), 2009-2014
  • Figure 3.5: Global-Contract Research & Manufacturing Market Forecast (in Billion US$), 2015-2020
  • Figure 3.6: Estimated Costs incurred in Various Pharmaceutical Operations
  • Figure 4.1: A Typical Drug Supply Chain from the Manufacturer to the End User
  • Figure 5.1: Global-Healthcare Cold Chain Logistic Services Market (in Billion US$), 2004-2014
  • Figure 5.2: Global-Healthcare Non Cold Chain Logistic Services Market (in Billion US$), 2004-2014
  • Figure 5.3: Global-Healthcare Logistic Services Market, Share of Cold-Chain and Non Cold-Chain Services*, (in %), 2014
  • Figure 5.4: Global-Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.5: Global-Healthcare Non Cold Chain Logistic Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.6: Global-Healthcare Logistic Services Market Forecast, Share of Cold-Chain and Non Cold-Chain Services*, (in %), 2020
  • Figure 5.7: Global-Healthcare Cold Chain Logistic Services Market by Product (in %), 2014 and 2020
  • Figure 5.8: Global-Clinical Trial Materials Cold Chain Logistic Services Market (in Billion US$), 2004-2014
  • Figure 5.9: Global-Clinical Trial Materials Cold Chain Logistic Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.10: Global-Vaccines Cold Chain Logistic Services Market (in Billion US$), 2004-2014
  • Figure 5.11: Global-Vaccines Cold Chain Logistic Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.12: Global-Biopharmaceuticals Cold Chain Logistic Services Market (in Billion US$), 2004-2014
  • Figure 5.13: Global-Biopharmaceuticals Cold Chain Logistic Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.14: Global-Healthcare Cold Chain Logistic Services Market by Segment (in %), 2014 and 2020
  • Figure 5.15: Global-Healthcare Cold Chain Transportation Services Market (in Billion US$), 2004-2014
  • Figure 5.16: Global-Healthcare Cold Chain Transportation Services Market: Breakup by Transportation Mode (in %), 2014
  • Figure 5.17: Global-Healthcare Cold Chain Transportation Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.18: Global-Healthcare Cold Chain Packaging Services Market (in Billion US$), 2004-2014
  • Figure 5.19: Global-Healthcare Cold Chain Packaging Services Market: Breakup by Packaging Type (in %), 2014
  • Figure 5.20: Global-Healthcare Cold Chain Instrumentation Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.21: Global-Healthcare Cold Chain Instrumentation Services Market (in Billion US$), 2004-2014
  • Figure 5.22: Global-Healthcare Cold Chain Instrumentation Services Market: Breakup by Instrumentation Type (in %), 2014
  • Figure 5.23: Global-Healthcare Cold Chain Instrumentation Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.24: Global-Healthcare Cold Chain Logistic Spending by Region (in US$ Billion), 2012, 2014, 2016, 2018 and 2020
  • Figure 5.25: North America-Healthcare Cold Chain Logistic Services Market-(in Billion US$), 2008-2014
  • Figure 5.26: North America-Healthcare Cold Chain Logistic Services Market Forecast-(in Billion US$), 2015-2020
  • Figure 5.27: Europe-Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008-2014
  • Figure 5.28: Europe-Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.29: Asia Pacific-Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008-2014
  • Figure 5.30: Asia Pacific-Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015-2020
  • Figure 5.31: Rest of the World-Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008-2014
  • Figure 5.32: Rest of the World-Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015-2020
  • Figure 6.1: Global-Healthcare Cold Chain Products Market-Breakup by Segment (in %), 2007-2014
  • Figure 6.2: Global-Healthcare Cold Chain Products Market Forecast-Breakup by Segment (in %), 2015-2020
  • Figure 6.3: Global-Biopharmaceutical Market (in Billion US$), 2007-2014
  • Figure 6.4: Global-Biopharmaceutical Market Forecast (in Billion US$), 2015-2020
  • Figure 6.5: Global-Biosimilar Sales and Forecast (in Million US$), 2014 and 2020
  • Figure 6.6: Global-Share of Biopharmaceutical Manufacturers Outsourcing Some Production to Contract Manufacturers (in %), 2006 and 2011
  • Figure 6.7: Global-Biopharmaceutical Contract Manufacturing Market (in Billion US$), 2011-2014
  • Figure 6.8: Global-Biopharmaceutical Contract Manufacturing Market Forecast (in Billion US$), 2015-2020
  • Figure 6.9: Global-Vaccine Market (in Billion US$), 2007-2014
  • Figure 6.10: Global-Vaccine Market Forecast (in Billion US$), 2015-2020
  • Figure 6.11: Global-Vaccine Production Volume by Region (in %), 2008*
  • Figure 6.12: Europe-Vaccine Export Volume by Region (in %), 2008*
  • Figure 6.13: Global-Clinical Trials Market (in Billion US$), 2007-2014
  • Figure 6.14: Global-Clinical Trials Market-Spending on Biopharmaceuticals & Small Molecule Drugs (in Billion US$), 2009-2014
  • Figure 6.15: Time Taken for Biopharmaceuticals to Get Approved (in Months), 1982-2009
  • Figure 6.16: Global-Clinical Trials Market Forecast (in Billion US$), 2015-2020
  • Figure 6.17: Global-Clinical Trials Market Forecast-Spending on Biopharmaceuticals & Small Molecule Drugs (in Billion US$), 2015-2020
  • Figure 6.18: Number of Multinational Clinical Trials (Phase II and III) in Asian Countries by the Top Twenty Global Pharmaceutical Companies*
  • Figure 6.19: Global-Breakup of Biopharmaceuticals and Small Molecule Drugs in Preclinical & Clinical trials, (in %), 2009
  • Figure 6.20: Top Reasons for Conducting Clinical Trials in Each Country (in %), 2009
  • Figure 7.1: Financing Sources and Gaps (in %), 2008-2010
  • Figure 8.1: Global-Exports of Temperature Sensitive Healthcare Products: Vaccines for Human Use (in Tons), 2007-2013
  • Figure 8.2: Global-Exports of Temperature Sensitive Healthcare Products: Vaccines for Veterinary Use (in Tons), 2007-2013
  • Figure 8.3: Global-Exports of Temperature Sensitive Healthcare Products: Antisera and Other Blood Fractions, (in Tons), 2007-2013
  • Figure 8.4: Global-Exports of Temperature Sensitive Healthcare Products: Human Blood, Animal Blood for Therapeutic, Prophylactic/Diagnostics Uses and Microbial Preparations, (in Tons), 2007-2013
  • Figure 8.5: Global-Exports of Temperature Sensitive Healthcare Products: Insulin in Dosage (in Tons), 2007-2013
  • Figure 8.6: Global-Exports of Temperature Sensitive Healthcare Products: Insulin Formulated in Bulk (in Tons), 2007-2013
  • Figure 8.7: Global-Exports of Temperature Sensitive Healthcare Products: Adrenal Cortex Hormones, in Dosage, (in Tons), 2007-2013
  • Figure 8.8: Global-Temperature Sensitive Healthcare Products: Vaccines for Human Use: Export Volume Breakup by Country (in %), 2013
  • Figure 8.9: Global-Temperature Sensitive Healthcare Products: Vaccines for Veterinary Use: Export Volume Breakup by Country (in %), 2013
  • Figure 8.10: Global-Temperature Sensitive Healthcare Products: Antisera and Other Blood Fractions: Export Volume Breakup by Country (in %), 2013
  • Figure 8.11: Global-Temperature Sensitive Healthcare Products: Human Blood, Animal Blood for Therapeutic, Prophylactic/Diagnostics Uses and Microbial Preparations: Export Volume Breakup by Country (in %), 2013
  • Figure 8.12: Global-Temperature Sensitive Healthcare Products: Insulin in Dosage: Export Volume Breakup by Country (in %), 2013
  • Figure 8.13: Global-Temperature Sensitive Healthcare Products: Insulin Formulated in Bulk: Export Volume Breakup by Country (in %), 2013
  • Figure 8.14: Global-Temperature Sensitive Healthcare Products: Adrenal Cortex Hormones in Dosage: Export Volume Breakup by Country (in %), 2013
  • Figure 8.15: Global-Imports of Temperature Sensitive Healthcare Products: Vaccines for Human Use (in Tons), 2007-2013
  • Figure 8.16: Global-Imports of Temperature Sensitive Healthcare Products: Vaccines for Veterinary Use (in Tons), 2007-2013
  • Figure 8.17: Global-Imports of Temperature Sensitive Healthcare Products: Antisera and Other Blood Fractions, (in Tons), 2007-2013
  • Figure 8.18: Global-Imports of Temperature Sensitive Healthcare Products: Human Blood, Animal Blood for Therapeutic, Prophylactic/Diagnostics Uses and Microbial Preparations, (in Tons), 2007-2013
  • Figure 8.19: Global-Imports of Temperature Sensitive Healthcare Products: Insulin in Dosage (in Tons), 2007-2013
  • Figure 8.20: Global-Imports of Temperature Sensitive Healthcare Products: Insulin Formulated in Bulk (in Tons), 2007-2013
  • Figure 8.21: Global-Imports of Temperature Sensitive Healthcare Products: Adrenal Cortex Hormones, in Dosage, (in Tons), 2007-2013
  • Figure 8.22: Global-Temperature Sensitive Healthcare Products: Vaccines for Human Use: Import Volume Breakup by Country (in %), 2013
  • Figure 8.23: Global-Temperature Sensitive Healthcare Products: Vaccines for Veterinary Use: Import Volume Breakup by Country (in %), 2013
  • Figure 8.24: Global-Temperature Sensitive Healthcare Products: Antisera and Other Blood Fractions: Import Volume Breakup by Country (in %), 2013
  • Figure 8.25: Global-Temperature Sensitive Healthcare Products: Human Blood, Animal Blood for Therapeutic, Prophylactic/Diagnostics Uses and Microbial Preparations: Import Volume Breakup by Country (in %), 2013
  • Figure 8.26: Global-Temperature Sensitive Healthcare Products: Insulin in Dosage: Import Volume Breakup by Country (in %), 2013
  • Figure 8.27: Global-Temperature Sensitive Healthcare Products: Insulin Formulated in Bulk: Import Volume Breakup by Country (in %), 2013
  • Figure 8.28: Global-Temperature Sensitive Healthcare Products: Adrenal Cortex Hormones in Dosage: Import Volume Breakup by Country (in %), 2013

List of Tables

  • Table 3.1: Various Regulations on Healthcare Cold Chain Logistic Requirements
  • Table 4.1: Average Amount of Dry Ice for Packaging Frozen Goods in a Single Well Insulated Container
  • Table 4.2: Dry Ice Containers
  • Table 4.3: Refrigerated Shipping Containers with Gel Packs
  • Table 4.4: Costs Associated With the Cold Chain Shipment of Healthcare Products, 2015*
  • Table 4.5: Costs Associated With the Non-Cold Chain Shipment of Healthcare Products, 2015
  • Table 5.1: Cold Chain Logistics: Comparison Matrix for Transport Modes
  • Table 6.1: Global-Healthcare Cold Chain Products Market-Breakup by Segment (in Billion US$), 2007-2014
  • Table 6.2: Global-Healthcare Cold Chain Products Market Forecast-Breakup by Segment (in Billion US$), 2015-2020
  • Table 6.3: Global-Biopharmaceutical Market-Sales by Class (in Billion US$), 2007-2014
  • Table 6.4: Global-Biopharmaceutical Market Forecast- Sales by Class (in Billion US$), 2015-2020
  • Table 6.5: Stability of Various Biopharmaceuticals at Room Temperature
  • Table 6.6: Complexity of the Manufacturing Process Involved with Biopharmaceuticals & Small Molecule Drugs
  • Table 6.7: Temperature Stability of Commonly Used Vaccines
  • Table 6.8: The Effect of Temperature Excursions on the Usability of Vaccines
  • Table 6.9: Global-Major Vaccine Production Sites (in Numbers), 2008*
  • Table 6.10: Ideal Storage Temperatures for Clinical Trial Materials
  • Table 7.1: Cold Chain & Logistic Funding Gaps Per Infant (in US$), 2008-2010
Back to Top